Trademark: 97447022
Word
ZEGFROVY
Status
Pending
Status Code
807
Status Date
Friday, March 15, 2024
Serial Number
97447022
Mark Type
3000
Filing Date
Tuesday, June 7, 2022
Published for Opposition
Tuesday, June 27, 2023

Trademark Owner History

Classifications
5 Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronchodilating preparations; by-products of the processing of cereals for dietetic or medical purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; candy for medical purposes; candy for pharmaceutical purpose for treatment of the cough; capsules made of dendrimer-based polymers for medicinal preparations for the mouth, for pharmaceuticals purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations as medicines for medical purposes, namely, for anti-tumor treatment; chemical preparations for pharmaceutical purposes for the treatment of human illnesses, namely, anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; chemico-pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; chewing gum for medical purposes; Chinese medicine nostrum for the treatment of tumors in humans; collyrium; contact lens cleaning preparations; contact lens disinfectant; contact lenses care solution; cough pastilles for pharmaceutical purposes; crystallized rock sugar for medical purposes; depuratives for the body; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic substances of low sugar and salt adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes for treatment of human illnesses, namely, anti-tumor treatment; enzyme preparations for medical purposes; enzymes for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; eye drops; filled portable medicine cases, comprised of pharmaceuticals for treatment of human illnesses, namely, anti-tumor treatment; first-aid boxes, filled; fungicides; gelatine for medical purposes, namely, gelatin capsules sold empty; germicides; herbal teas for medicinal purposes; insect killing preparations in the nature of pesticides; insecticidal veterinary washes; insecticides; isotopes for medical purposes; media for bacteriological cultures; medical diagnosis reagent; medical probiotic supplements; medicated eye-washes; medicated lozenges for pharmaceutical purposes; medicinal drinks; medicinal hair growth preparations; medicinal preparations for the mouth to be applied in the form of capsules; medicines for alleviating constipation; medicines for dental purposes; mineral, bath and sodium salts for medical purposes; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; opotherapy preparations; organotherapy preparations; pesticides; petroleum jelly for medical purposes; pharmaceutical blood preparations, namely, a blood clotting aid and delivery system for use in human medicine; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; pharmaceutical preparations for skin care; pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; pharmaceutical preparations, namely, elixirs for anti-tumor treatment; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposes, namely, anti-tumor treatment; preparations for destroying noxious animals; protein dietary supplements; radioactive substances for medical purposes; radiological contrast substances for medical purposes; rat poison; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; reagent paper for medical purposes; reagent paper for veterinary purposes; rubbing alcohol; solutions for contact lenses; stem cells for medical purposes; sterilizing preparations; styptic preparations; tonics being pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; vaccine preparations; bacteriological preparations for veterinary use; cultures of microorganisms for veterinary use; chemical reagents for veterinary purposes; veterinary preparations for the treatment of intestinal bacteria; diagnostic preparations for veterinary use
The mark consists of the literal element "ZEGFROVY" to the right of a design consisting of two pairs of differing fanciful geometric shapes intended to depict a gene mutation process.
Color is not claimed as a feature of the mark.
The wording ZEGFROVY has no meaning in a foreign language.

Trademark Events
Mar 15, 2024
Notification Of Non-Final Action E-Mailed
Mar 15, 2024
Non-Final Action E-Mailed
Mar 15, 2024
Su - Non-Final Action - Written
Feb 29, 2024
Statement Of Use Processing Complete
Feb 6, 2024
Use Amendment Filed
Feb 29, 2024
Case Assigned To Intent To Use Paralegal
Feb 6, 2024
Teas Statement Of Use Received
Aug 22, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 27, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 27, 2023
Published For Opposition
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 25, 2023
Approved For Pub - Principal Register
May 22, 2023
Teas/Email Correspondence Entered
May 22, 2023
Correspondence Received In Law Office
May 22, 2023
Teas Response To Office Action Received
Mar 22, 2023
Notification Of Non-Final Action E-Mailed
Mar 22, 2023
Non-Final Action E-Mailed
Mar 22, 2023
Non-Final Action Written
Mar 22, 2023
Assigned To Examiner
Jun 17, 2022
Notice Of Design Search Code E-Mailed
Jun 16, 2022
New Application Office Supplied Data Entered
Jun 10, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24